Quality-of-Life Assessment for Cancer During COVID-19

LC
Overseen ByLorenzo Cohen
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to understand how the COVID-19 pandemic has affected the well-being and quality of life for individuals with cancer or those who have survived it. Participants will complete a short online survey about their pandemic experiences, including testing, exposure risks, and the impact on their physical, emotional, and social well-being. The trial also examines COVID-19-related stress and any disruptions to healthcare or daily life. It is suitable for cancer patients or survivors who have been patients at MD Anderson in the past five years and can complete an online questionnaire in English or Spanish. As an unphased trial, this study offers a unique opportunity to contribute to understanding the broader impact of the pandemic on cancer patients and survivors.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It seems to focus on surveys about well-being and quality of life, so it's unlikely that medication changes are required.

Why are researchers excited about this trial?

Researchers are excited about this trial because it aims to understand how the COVID-19 pandemic has affected the quality of life for cancer patients and survivors, which is different from typical treatments that focus on directly addressing cancer symptoms or progression. Unlike standard medical treatments, this approach involves administering a questionnaire to gather insights into patients' personal experiences during the pandemic. By focusing on patients' well-being and life quality, the trial seeks to uncover vital information that could lead to improved support systems and resources for cancer patients, especially during global health crises like COVID-19.

Who Is on the Research Team?

LC

Lorenzo Cohen

Principal Investigator

M.D. Anderson Cancer Center

Are You a Good Fit for This Trial?

Inclusion Criteria

ICD-10 confirmed cancer diagnosis
Documentation of being alive per the cancer registry
Patients who have signed consent for one of the following protocols: PA14-0241 or LAB03-0320
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Questionnaire Completion

Participants complete an online questionnaire regarding the COVID-19 pandemic, including testing, risks of exposure, and impacts on quality of life

10 minutes

Follow-up

Participants are monitored for changes in well-being and quality of life over the study period

8 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Quality-of-Life Assessment
  • Questionnaire Administration

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Observational (questionnaire)Experimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+